Anticorps Monoclonal anti-TREM2
TREM2 Monoclonal Antibody for WB, IF-P, ELISA
Hôte / Isotype
Mouse / IgG1
Réactivité testée
Humain, rat, souris
Applications
WB, IF-P, CoIP, ELISA
Conjugaison
Non conjugué
CloneNo.
1F4H10
N° de cat : 68723-1-Ig
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en WB | cellules THP-1 |
Résultats positifs en IF-P | tissu cérébral de souris, tissu cérébral de rat |
Dilution recommandée
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:1000-1:5000 |
Immunofluorescence (IF)-P | IF-P : 1:200-1:800 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Applications publiées
WB | See 1 publications below |
IF | See 2 publications below |
CoIP | See 1 publications below |
Informations sur le produit
68723-1-Ig cible TREM2 dans les applications de WB, IF-P, CoIP, ELISA et montre une réactivité avec des échantillons Humain, rat, souris
Réactivité | Humain, rat, souris |
Réactivité citée | souris |
Hôte / Isotype | Mouse / IgG1 |
Clonalité | Monoclonal |
Type | Anticorps |
Immunogène | TREM2 Protéine recombinante Ag6843 |
Nom complet | triggering receptor expressed on myeloid cells 2 |
Masse moléculaire calculée | 222 aa, 25 kDa |
Poids moléculaire observé | 26-32 kDa |
Numéro d’acquisition GenBank | BC032362 |
Symbole du gène | TREM2 |
Identification du gène (NCBI) | 54209 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Purification par protéine G |
Tampon de stockage | PBS with 0.02% sodium azide and 50% glycerol |
Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
TREM2 (triggering receptor expressed on myeloid cells 2) is a cell surface receptor belongs to TREM family that is expressed on osteoclast, dendritic cells, macrophages, nature killers, neutrophils and microglia (PMID: 19302484). TREM2 is localized predominantly in the Golgi complex, but also shuttles to and from the cell surface in endocytic and exocytic vesicles (PMID: 16675145). TREM2 associates with DAP12 to initiate the intracellular signalling cascade via an immunoreceptor tyrosine-based activation motif (ITAM) domain and tyrosine-kinases (PMID: 23977213). TREM2 has a calculated molecular mass of ~25kDa, but apparent molecular mass of ~40kDa (PMID: 24078628). In addition, TREM2 has a soluble form termed as sTREM-2 with molecular weights ranging between about 24kDa and 40kDa (PMID: 18790823). Loss-of-function mutations in either TREM2 or DAP12 can cause Nasu-Hakola disease (PMID: 19302484).
Protocole
Product Specific Protocols | |
---|---|
WB protocol for TREM2 antibody 68723-1-Ig | Download protocol |
IF protocol for TREM2 antibody 68723-1-Ig | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Hepatol Int A robust diagnostic model for high-risk MASH: integrating clinical parameters and circulating biomarkers through a multi-omics approach | ||
Front Neurosci Perioperative enriched environment attenuates postoperative cognitive dysfunction by upregulating microglia TREM2 via PI3K/Akt pathway in mouse model of ischemic stroke | ||
J Alzheimers Dis IL-34/TREM2 modulates microglia-mediated inflammation and provides neuroprotection in a mouse model of sporadic Alzheimer's disease |